Welcome to our dedicated page for Tredegar SEC filings (Ticker: TG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Resin costs up, aluminum prices volatile, two operating segments spread across continents—Tredegar Corporation’s disclosures rarely fit a tidy summary. If you have ever searched for “Tredegar insider trading Form 4 transactions” or wondered how raw-material swings flow through earnings, you know each filing can run hundreds of pages.
Stock Titan solves that problem. Our AI reads every Tredegar quarterly earnings report 10-Q filing, flags where polypropylene prices hit margins, and decodes supplier-risk language—all in plain English. Need real-time alerts? The moment a director buys shares, you’ll see Tredegar Form 4 insider transactions real-time. Our coverage spans the entire EDGAR feed, so whether you’re checking an 8-K material events explained notice about a plant shutdown or seeking a Tredegar proxy statement executive compensation table, the information is immediately available and clearly summarized.
Investors use these insights to:
- Track segment profitability across films and aluminum extrusions without wading through footnotes.
- Monitor Tredegar executive stock transactions Form 4 ahead of commodity price moves.
- Compare cash-flow projections via our AI-driven Tredegar earnings report filing analysis.
The platform also offers “understanding Tredegar SEC documents with AI” guides for newcomers and a one-click download of the Tredegar annual report 10-K simplified into an annotated PDF. Every disclosure—from risk factors to segment EBIT—is parsed so you can decide faster, with greater confidence.
TG filed a Form 144 notice for a proposed sale of 349,106 shares of common stock, with an aggregate market value of $2,195,875.00. The filing lists Truist Investment Services Inc. as broker and the NYSE as the exchange, with an approximate sale date of 11/10/2025.
The shares were originally acquired by the FDGJr Living Trust in January 2022 and recorded as an inheritance with a payment date of 01/29/2024. As context, 34,910,693 shares were outstanding. Recent sales over the past three months included multiple transactions by a related trust, reflecting ongoing disposition activity.
Tredegar Corporation furnished a press release announcing its results of operations for the third quarter ended September 30, 2025. The release is provided as Exhibit 99 to this report.
Consistent with Item 2.02 treatment, the information in this report, including Exhibit 99, is furnished, not filed, and is not subject to Section 18 liabilities of the Exchange Act, nor incorporated by reference into other filings except as specifically stated.
Tredegar Corporation (TG) reported a strong turnaround in Q3 2025. Sales rose to $194.9 million from $146.1 million, and net income from continuing operations improved to $7.1 million ($0.20 per diluted share) from a loss a year ago. Gross margin expanded to 16.0% from 12.4% as volumes and pricing improved, particularly in Aluminum Extrusions.
Aluminum Extrusions delivered EBITDA from ongoing operations of $16.8 million (vs. $6.2 million), driven by higher volume and favorable pricing, while PE Films posted $7.2 million (vs. $5.9 million). Nine-month sales reached $538.8 million (vs. $444.0 million) with net income from continuing operations of $9.6 million. Including discontinued operations, nine-month net income was $18.9 million, reflecting the completed sale of Terphane.
Liquidity improved: cash was $13.3 million (vs. $7.1 million at year-end), ABL revolver borrowings were $49.5 million (vs. $60.6 million), and availability under the $125 million ABL Facility was $72.5 million. Operating cash flow for the first nine months was $17.3 million (vs. $6.1 million). Shares outstanding were 34,910,693 as of October 31, 2025.
Tredegar Corporation reported that D. Andrew Edwards, its Executive Vice President and Chief Financial Officer, informed the company on
George C. Freeman III, a director of Tredegar Corp (TG), purchased 2,844 shares of Tredegar common stock on 10/01/2025 at a price of $7.91 per share. After the transaction, the reporting person beneficially owned 75,562 shares. The Form 4 was filed as a single reporting person filing and the signature on the form is by an attorney-in-fact, Kevin C. Donnelly, dated 10/03/2025. No derivative securities were reported on this Form 4.
Christine R. Vlahcevic, a director of Tredegar Corporation (TG), reported a personal purchase of 2,844 shares of Tredegar common stock on 10/01/2025 at a price of $7.91 per share. After the transaction she beneficially owned 7,986 shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing shows a straightforward open-market acquisition with no derivatives, amendments, or additional explanatory text provided.
Tredegar Corp director Kenneth Newsome reported a purchase of 2,844 shares of Tredegar common stock (TG) on 10/01/2025 at a per-share price of $7.91. After the transaction, the reporting person beneficially owned 73,059 shares. The Form 4 was signed by an attorney-in-fact, Kevin C. Donnelly, on 10/03/2025. The filing indicates the report was made by one reporting person and identifies Newsome as a Director. No derivative transactions or additional explanatory text are included in the filing.
Tredegar Corp director Thomas G. Snead Jr. reported purchasing 2,844 shares of Tredegar common stock (TG) on 10/01/2025 at a price of $7.91 per share. After the transaction he beneficially owns 74,661 shares. The Form 4 was signed via attorney-in-fact on 10/03/2025. No derivative transactions or additional details were disclosed in this filing.
TREDEGAR CORP (TG) director Carl E. Tack III reported an open-market purchase of 2,844 shares of Tredegar common stock on 10/01/2025 at a reported price of $7.91 per share. After the transaction he beneficially owns 73,059 shares. The Form 4 was signed by an attorney-in-fact on 10/03/2025. The filing records a direct acquisition and does not disclose any derivative transactions.
Gregory A. Pratt, a director of Tredegar Corp (TG), reported a purchase of 3,871 shares of Tredegar common stock at $7.91 per share. Following the transaction, Mr. Pratt beneficially owns 86,223 shares. The Form 4 discloses this non-derivative acquisition and lists Kevin C. Donnelly as attorney-in-fact on the filing.
FAQ
What is the current stock price of Tredegar (TG)?
What is the market cap of Tredegar (TG)?
